Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ralston

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 proteaseX Tong, A Arasappan, F Bennett, et al.
Journal of Nephrology|November 2, 2024
Premature mortality and disparities in kidney healthcare for people with chronic kidney disease and severe mental health difficultiesClodagh Cogley, Mimi Smith-Jones, Elizabeth R Ralston, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
Kidney International|February 21, 2024
Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counselingMargriet E Gosselink, Rozemarijn Snoek, Agne Cerkauskaite-Kerpauskiene, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Antimicrobial Agents and Chemotherapy|March 24, 2010
Preclinical characterization of the antiviral activity of SCH 900518 (narlaprevir), a novel mechanism-based inhibitor of hepatitis C virus NS3 proteaseX Tong, A Arasappan, F Bennett, et al.
Journal of Nephrology|November 2, 2024
Premature mortality and disparities in kidney healthcare for people with chronic kidney disease and severe mental health difficultiesClodagh Cogley, Mimi Smith-Jones, Elizabeth R Ralston, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
Kidney International|February 21, 2024
Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counselingMargriet E Gosselink, Rozemarijn Snoek, Agne Cerkauskaite-Kerpauskiene, et al.
Pageof 8